White House, NIH Directors Weigh in on Proposed Health and Human Services Research Arm

metamorworks/istockphoto

The proposed $6.5 billion Advanced Research Projects Agency for Health will need a very specific work culture and an inspiring first leader to be successful, key officials said.

An advanced, government-run research center devoted to driving and funding breakthroughs in medicine and health care will need the right culture and a galvanizing first director to succeed, according to federal officials leading the government’s research efforts today.

Among the proposals to boost American research and development capabilities included in President Joe Biden’s 2022 budget is a move to establish a public health-focused version of research organizations like the Defense Advanced Research Programs Agency, better known as DARPA.

The president’s budget included $6.5 billion to create the Advanced Research Projects Agency for Health, or ARPA-H, within the Health and Human Services Department’s National Institutes of Health.

During an informational session held Friday, officials from NIH and the White House Office of Science and Technology Policy, or OSTP, offered some insight into what such an agency would look like, what it’s mission would be and how that would fit with other health-focused agencies—especially the research programs at NIH—and other research organizations, such as DARPA, the Energy Department’s ARPA-E and intelligence community’s IARPA.

While such an agency would be focused on treating and potentially curing diseases and conditions like cancer, diabetes and Alzheimer’s, the big ambition will be to develop new sciences that could be applied to a range of conditions.

OSTP Director Eric Lander suggested using gene mapping to target the cause of a given illness as a prime example.

“The most exciting things that ARPA-H can work on would transcend any one disease,” he said. “It would be platforms that would be, technologies that would be applicable across many diseases.”

The federal government already has research efforts targeting critical public health issues, including ongoing programs at NIH. But ARPA-H would fill a unique role.

“A potential version of the mission could read something like, ‘To make pivotal investments in breakthrough technologies and broadly applicable platforms, capabilities, resources, solutions that have the potential to transform areas of medicine and health for the benefit of all patients, and that cannot readily be accomplished through traditional research or commercial activity,” OSTP Assistant Director for Biomedical Initiatives Tara Schwetz said, stressing the last point. “What we’re talking about is doing things that can’t currently be done.”

That includes important breakthroughs that need to be made faster, according to NIH Director Francis Collins.

“What becomes possible with this new entity on the scene: Science that we might otherwise have to delay or which would take a long time, with this approach, maybe could be done twice as quickly,” he said. “To the benefit of everybody.”

Collins and Schwetz both cited the speed with which the U.S. was able to develop a vaccine for COVID-19, hoping ARPA-H could replicate and improve that timeline in a future pandemic.

“We stand on an unprecedented moment of progress that challenges us to ask, ‘What more can we do?’” Schwetz said. “What more can we do to speed, revolutionize, transform medicine and improve the health of all Americans?”

While ARPA-H is still just a proposal awaiting action from Congress, Schwetz laid out some potential goals for such an organization:

  • Build capabilities and platforms that are broadly applicable across a range of diseases and conditions to revolutionize how we treat and cure them.
  • Focus on converting use-driven ideas—those ideas with a direct application—into solutions for patients quickly.
  • Embracing this sense of urgency to speed the application and implementation of breakthroughs at various levels—from the molecular to the societal—so that they serve all people.
  • Help overcome market failures through creative solutions, incentives and de-risking.

Schwetz noted the culture of the program will be key to its success, particularly how it interacts with other research programs at NIH.

“APRA-H is proposed as, and is important to be linked to NIH to draw on the vast knowledge, expertise and infrastructure,” she said. “However, it will be important for it to remain distinct, with its own unique culture, organization and autonomy.”

As such, program managers will be given “broad autonomy” to manage their research areas as they see fit.

As with other research organizations, such as the other ARPAs, ARPA-H will be built with a tolerance for failure—or a certain level of “risk acceptance,” as Schwetz put it.

But APRA-H won’t be exactly like the other ARPAs, Lander said.

“There’s a lot about the DARPA model that is a fantastic inspiration for APRA-H: the way it’s organized with a great deal of autonomy and people coming for limited terms and tolerating—in fact, embracing—failure. All those things are good,” he said.

However, understanding how ARPA-H will differ from other research organizations is just as important, he said.

DARPA, for instance, “has a single customer: the Department of Defense,” Lander noted. “ARPA-H has an entire ecosystem of customers.”

Similarly, while DARPA is mostly focused on physical engineering feats—GPS, self-driving cars, the internet—biological research is very different, including being simultaneously more complicated and less understood. This will mean structuring research programs differently while trying to absorb the appropriate lessons DARPA and others have learned over decades in operation.

“What will come out is something that’s different from, inspired by,” Lander said. “It will be an ARPA; but it will be its own ARPA-H.”

If established by Congress, Schwetz said the agency will have a “flat, dynamic organizational structure to limit the potential for unnecessary bureaucracy,” with the goal of “instilling a sense of urgency, nimbleness and innovation.”

The White House plans to ensure ARPA-H remains “dynamic” by instituting term limits for the director and other top leadership positions.

Schwetz said the first director will be an important choice, as it will set the tenor for all future leaders of the organization. She said the inaugural leader should be someone with deep technical skills and proven leadership qualities.

Lander echoed that sentiment.

“They’ve got to be somebody who’s been around innovation and has a proven track record building an innovative culture,” he said. “Somebody inspiring, but also somebody who knows they don’t have all the ideas.”

Ideally, the first ARPA-H director would be someone who would attract the top minds in medical research to come forward and either join the agency or work directly with one of its programs.

“That person has to be able to recruit those people, support those people and also has to have their back to make sure they feel comfortable taking risks on projects,” Lander said.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.